戻る Agenda
Value and Access for Special Populations: From Access Restriction to Drug Mortgages
Session Chair(s)
Roxanne Tavakkol, MS
Vice President, Regulatory Affairs, Autoimmune and Rare Diseases
Mallinckrodt Pharmaceuticals, United States
Therapies for rare diseases present particular challenges for access, distribution, and coverage. This session will provide insights into the steps required for patient access to approved and unapproved products as well as distribution and current legal framework challenges. Attendees will learn how to overcome barriers today for improved access tomorrow.
Learning Objective : Identify challenges impacting drug availability in rare diseases; Define scope of legal and regulatory framework for market access.
Speaker(s)
Addressing Urgent Access to Therapeutic Treatment Needs: Meeting the Need for Urgent Access to Therapeutic Treatments
Roxanne Tavakkol, MS
Mallinckrodt Pharmaceuticals, United States
Vice President, Regulatory Affairs, Autoimmune and Rare Diseases
Panelist
William A. Sarraille, JD
Sidley Austin, LLP, United States
Partner
Gaining Access to Orphan/Special Drug Therapies
John J. Maddox, MBA, RPH
Infusion Pharma Consulting LLC, United States
Founder & Managing Director